Prinicples of coag Flashcards
Describe the 1st phase of coagulation.
Phase 1: The first phase consists of localized vasoconstriction which occurs near the
site of vessel injury and is initiated by reflex neurogenic mechanisms as well as by
the release of vasoconstrictor substances such as endothelin which are derived from
endothelial cells. The function of localized vasoconstriction is to reduce the
magnitude of blood loss by decreasing blood flow to the injured area. In addition, the
narrowing of the blood vessel leads to a redistribution of the flowing elements in
blood such that the red blood cells and white cells are carried into the center of the
flowing stream and the platelets and coagulation proteins are moved to the outer
edge which enhances their interaction with the vessel wall
Describe phase 2 of coagulation
Phase 2: The second phase is called primary hemostasis which refers to the
interactions that occur between blood platelets and exposed subendothelial collagen.
Platelets adhere to collagen by an interaction involving a protein called von
Willebrand Factor and specific surface membrane glycoprotein receptors on the
platelet. Following adhesion, platelets undergo a shape change in which the
individual platelets begin to spread out over the exposed collagen surface.
Following shape change, the adherent platelets are stimulated to release substances
contained within specific granules inside of the platelet. These substances lead to
activation of additional platelets in the area which then can bind to other regions of
exposed collagen or to other platelets in a process referred to as platelet recruitment.
Platelet-platelet interaction leads to further stimulation and granule release by a process
called platelet aggregation. Eventually, enough platelets accumulate at the site to
form a primary hemostatic plug that stops further blood loss (see Figure 3).
Describe phase 3 of coagulation.
Phase 3: The third phase of hemostasis is referred to as secondary hemostasis and
consists of a complex series of reactions referred to as the coagulation cascade. The
coagulation cascade is activated when circulating plasma proteins encounter
endothelial cells which have expressed tissue factor, a membrane bound procoagulant
protein synthesized by endothelial cells which is exposed at the site of vascular injury.
Exposure of plasma proteins to tissue factor leads to formation of a protease
called thrombin by a sequential series of calcium and phospholipid- activated
reactions that are localized to the membrane surface of platelets present in the
primary hemostatic plug. Once formed, thrombin cleaves another soluble circulating
plasma protein called fibrinogen to form an insoluble fibrin polymer. The fibrin
polymer forms a matrix that surrounds and traps the platelets and essentially cements
them together stabilizing the primary hemostatic plug. As the fibrin polymer forms,
circulating white blood cells and red blood cells also may become trapped within the
growing thrombus (see Figure 4).
Describe phase 4 of coagulation.
Phase 4: The final phase of hemostasis consists of a series of events in which: 1) the
thrombotic process is terminated by counter-regulatory mechanisms (such as
thrombomodulin produced by endothelial cells) and 2) the fibrin polymer which is
formed at the site, undergoes remodeling by a process referred to as fibrinolysis
(initiated by two endothelial cell proteins referred to as tissue type plasminogen
activator or TPA and urokinase plasminogen activator or UPA).
Fibrinolytic remodeling of the thrombus begins at the outer surface of the clot and
proceeds relatively slowly. When the thrombus is shrinks sufficiently, endothelial cells
will proliferate and restore a contiguous endothelial surface. The function of this
process is to eventually allow for restoration of blood flow to the tissue distal to the site
of injury in order to maintain the viability of the cells in that region (see Figure 5 and
Figure 6).
Describe various regulatory mechanisms that keep coagulation localized and rapid.
To function effectively, the hemostatic process must be rapid and localized to the site
of vascular injury. Primary hemostasis is localized by specific interactions of platelets
with subendothelial matrix components that are only exposed at the site of vessel
injury. Secondary hemostasis is in part localized by virtue of the fact that certain
critical reactions in the coagulation cascade are dependent on the presence of specific
anionic phospholipids which are exposed on the membrane surface of platelets
which accumulate at the site. Other important factors which control the hemostatic
process include blood flow itself which reduces the chance of a localized concentration
of precursors building up and removes activated materials by dilution into a larger
volume of flowing blood. Plasma also contains a number of inhibitors which
inactivate proteases generated by the coagulation cascade. Endothelial cells also play
a vitally important role in regulating normal hemostasis. Endothelial cells possess a
number of clot-promoting or procoagulant activities as well as a number of clot-
inhibiting or anti-coagulant activities. The critical role of these regulatory mechanisms
will be discussed in more detail in future lectures.